RTW Investments Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 19
- Investments
- 69
- Portfolio
- 30
- Exits
- 46
RTW Investments General Information
Description
Founded in 2009, RTW Investments is a venture capital firm based in New York, New York. The firm prefers to invest in the life sciences, big data, and digital health sectors.
Contact Information
Website
www.rtwfunds.com
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 40 10th Avenue
- Floor 7
- New York, NY 10014
- United States
+1 (646) 000-0000
RTW Investments Investments (69)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Umoja Biopharma | 15-Jun-2021 | Early Stage VC | 00000 | Drug Discovery | Pre-Clinical Trials | |
| 0000000 0000000000 | 09-Jun-2021 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 0000000 00000000000 |
| 000000 00000000000 | 26-May-2021 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - General | 00000000 0000 00 |
| 00000 000000000000 | 20-May-2021 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 1 | |
| 0000 0000000000 | 17-May-2021 | 0000 | 00000 | Drug Discovery | Clinical Trials - Phase 2 | |
| 0000000 00 | 07-May-2021 | 0000 | 00000 | Enterprise Systems (Healthcare) | Generating Revenue | |
| 00000000000 000000 | 04-May-2021 | 0000 | 00000 | Laboratory Services (Healthcare) | Profitable | |
| 0000000 00000000 | 03-May-2021 | 0000 | 00000 | Biotechnology | Generating Revenue | |
| GH Research | 12-Apr-2021 | Later Stage VC | 00000 | Drug Discovery | Clinical Trials - Phase 1 | |
| Renovacor | 23-Mar-2021 | PIPE | 0000 | Drug Discovery | Generating Revenue |
RTW Investments Exits (46)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Biomea Fusion | 16-Apr-2021 | IPO | 00000 |
| 0000000000 0000000 | 12-Mar-2021 | 000 | 00000 |
| 0000000000 | 05-Feb-2021 | 000 | 00000 |
| 000000 000000000 | 04-Feb-2021 | 000 | 00000 |
| 000000 00000000000 | 16-Oct-2020 | 000 | 0000 |
| 00 000000000000 | 02-Oct-2020 | 000 | 00000 |
| 0000000 | 01-Oct-2020 | 000 | 00000 |
| 000000000 00000000 | 28-Sep-2020 | 000000000000000000 | 00.000 |
| Athira Pharma | 18-Sep-2020 | IPO | 00000 |
| Health Sciences Acquisitions Corporation 2 | 04-Aug-2020 | IPO | 00000 |
RTW Investments Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialRTW Investments Team (23)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Robert Aurigema | Chief Financial Officer | New York, NY | |||
| Sabera Loughran | Partner & Chief Operating Officer | New York, NY | |||
| Peter Fong Ph.D | Senior Managing Director & Head of Company Creation | New York, NY | |||
| Paul Lu Ph.D | Managing Director & Head, Business Development | New York, NY | |||
| Piratip Pratumsuwan | Managing Director & Research Analyst | 0 | 0 | New York, NY |
RTW Investments Co-Investors (207)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Cormorant Asset Management | 14 | 0 | 0 |
|
|
| Perceptive Advisors | 00 | 0 |
|
|
|
| RA Capital Management | 00 | 0 |
|
|
|
| Janus Henderson Investors | 0 | 0 |
|
|
|
| HBM Healthcare Investments | 0 | 0 | 0 |
|
|